Cargando…

Reciprocal regulation of DGCR5 and miR-320a affects the cellular malignant phenotype and 5-FU response in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal malignancies. Long non-coding microRNAs (lncRNAs) are a newly discovered type of regulatory molecule with both diagnostic and prognostic value, but the role of lncRNA in PDAC has not been well investigated until now. He...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yong, Sun, Yabin, Yu, Bing, Zhou, Chuanrong, Zhu, Dianhua, Gu, Jianhuai, Zhang, Weidong, Yuan, Shuming, Wang, Ling, Liu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710890/ https://www.ncbi.nlm.nih.gov/pubmed/29207609 http://dx.doi.org/10.18632/oncotarget.18377

Ejemplares similares

Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma
por: Öman, Mikael, et al.
Publicado: (2021)

MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells
por: Wang, Weibin, et al.
Publicado: (2016)

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
por: De Angelis, Paula M, et al.
Publicado: (2006)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens
por: Chaigneau, Thomas, et al.
Publicado: (2023)

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

Large-Scale Analysis Reveals the Specific Clinical and Immune Features of DGCR5 in Glioma
por: Wu, Xuechao, et al.
Publicado: (2020)

Up‐regulation of CDHR5 expression promotes malignant phenotype of pancreatic ductal adenocarcinoma
por: Gao, Junyi, et al.
Publicado: (2020)

Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
por: Fu, Jinbo, et al.
Publicado: (2019)

LncRNA DGCR5 Isoform-1 Silencing Suppresses the Malignant Phenotype of Clear Cell Renal Cell Carcinoma via miR-211-5p/Snail Signal Axis
por: Zhong, Guang-Xin, et al.
Publicado: (2021)

No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion.
por: Fleming, R. A., et al.
Publicado: (1992)

5-FU toxicity and nutritional deficiencies.
por: Stenram, U.
Publicado: (1993)

Fluorouracil (5-FU)-induced Cardiomyopathy
por: Thalambedu, Nishanth, et al.
Publicado: (2019)

Dysregulation of DGCR6 and DGCR6L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome
por: Chakraborty, D, et al.
Publicado: (2012)

Dysregulation of DGCR6 and DGCR6 L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome
por: Chakraborty, D, et al.
Publicado: (2012)

Deconvoluting cellular neighborhoods in pancreatic ductal adenocarcinoma
por: Lal, Jessica Castrillon
Publicado: (2022)

Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure
por: Dolat, Marine, et al.
Publicado: (2020)

STAT5A induced LINC01198 promotes proliferation of glioma cells through stabilizing DGCR8
por: Tan, Cheng, et al.
Publicado: (2020)

A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma
por: Singhal, Ruchi, et al.
Publicado: (2023)

The effects of aberrant expression of LncRNA DGCR5/miR‐873‐5p/TUSC3 in lung cancer cell progression
por: Luo, Judong, et al.
Publicado: (2018)

Stabilizing heterochromatin by DGCR8 alleviates senescence and osteoarthritis
por: Deng, Liping, et al.
Publicado: (2019)

Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment
por: Anaka, Matthew, et al.
Publicado: (2022)

Whole transcriptome sequence data of 5-FU sensitive and 5-FU resistant tumors generated in a mouse model of de novo carcinogenesis
por: Iacovides, Demetris, et al.
Publicado: (2018)

Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer
por: Chen, Hongxiao, et al.
Publicado: (2019)

Correction for: STAT5A induced LINC01198 promotes proliferation of glioma cells through stabilizing DGCR8
por: Tan, Cheng, et al.
Publicado: (2021)

Effect of Skimmed Milk on the Absorption and Metabolism of5-Fluorouracil (5-FU) in Animals
por: Ahmad, Maqsood, et al.
Publicado: (2012)

A unique presentation of 5-fluorouracil (5-FU) induced cerebral encephalopathy
por: Naik, Shailendra S, et al.
Publicado: (2020)

Schlafen 5 as a Novel Therapeutic Target in Pancreatic Ductal Adenocarcinoma
por: Fischietti, Mariafausta, et al.
Publicado: (2021)

Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma
por: Li, Jingbo, et al.
Publicado: (2021)

Immunohistochemical Expression and Prognostic Value of CD97 and Its Ligand CD55 in Primary Gallbladder Carcinoma
por: Wu, Jinsheng, et al.
Publicado: (2012)

The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
por: Liu, Xiaomeng, et al.
Publicado: (2019)

DGCR8 HITS-CLIP reveals novel functions for the Microprocessor
por: Macias, Sara, et al.
Publicado: (2012)

Genetic polymorphism in DGCR8 is associated with late onset of preeclampsia
por: Huang, Xin, et al.
Publicado: (2019)

Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) ± folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients
por: Bensmaïne, M A, et al.
Publicado: (2001)

5-FU-induced cardiac toxicity - an underestimated problem in radiooncology?
por: Steger, Felix, et al.
Publicado: (2012)

The role of GLI1 for 5-Fu resistance in colorectal cancer
por: Zhang, Lining, et al.
Publicado: (2017)

5-FU induced cardiotoxicity: case series and review of the literature
por: Yuan, Cai, et al.
Publicado: (2019)

Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases.
por: Goldberg, J. A., et al.
Publicado: (1988)

MRGBP as a potential biomarker for the malignancy of pancreatic ductal adenocarcinoma
por: Ding, Feng, et al.
Publicado: (2017)

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]
por: Knaebel, HP, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_rs5erf72qo7v7s9ddrjk90p4jc